The new funding will also support the development of new diagnostics for genetic diseases and cancer, alongside expanding production capacity by tenfold. Last April, Reme-D secured a $500,000 investment from the Global Innovation Fund (GIF) to scale its molecular diagnostics solutions. Press release:Reme-D, an Egyptian healthtech company developing and manufacturing molecular diagnostic solutions, has closed a $1.45 million Pre-Series A funding round led by Anara Impact Capital, with participation from the Global Innovation Fund, Africa Health Ventures, and other investors. The funds from this round will help Reme-D expand its manufacturing capacity, regional reach, and product portfolio. Reme-D has already demonstrated that high-quality molecular diagnostics can be developed and manufactured locally, and we are excited to support the team as they scale their impact across MEA and beyond.”